• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管组织特异性微小RNA谱揭示了与冠状动脉疾病危险因素的新关联。

Vascular Tissue Specific miRNA Profiles Reveal Novel Correlations with Risk Factors in Coronary Artery Disease.

作者信息

Neiburga Katrīna D, Vilne Baiba, Bauer Sabine, Bongiovanni Dario, Ziegler Tilman, Lachmann Mark, Wengert Simon, Hawe Johann S, Güldener Ulrich, Westerlund Annie M, Li Ling, Pang Shichao, Yang Chuhua, Saar Kathrin, Huebner Norbert, Maegdefessel Lars, Lange Rüdiger, Krane Markus, Schunkert Heribert, von Scheidt Moritz

机构信息

Bioinformatics Lab, Riga Stradiņš University, LV-1007 Riga, Latvia.

SIA Net-OMICS, LV-1011 Riga, Latvia.

出版信息

Biomolecules. 2021 Nov 12;11(11):1683. doi: 10.3390/biom11111683.

DOI:10.3390/biom11111683
PMID:34827683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615466/
Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Non-coding RNAs have already been linked to CVD development and progression. While microRNAs (miRs) have been well studied in blood samples, there is little data on tissue-specific miRs in cardiovascular relevant tissues and their relation to cardiovascular risk factors. Tissue-specific miRs derived from (IMA) from 192 coronary artery disease (CAD) patients undergoing coronary artery bypass grafting (CABG) were analyzed. The aims of the study were 1) to establish a reference atlas which can be utilized for identification of novel diagnostic biomarkers and potential therapeutic targets, and 2) to relate these miRs to cardiovascular risk factors. Overall, 393 individual miRs showed sufficient expression levels and passed quality control for further analysis. We identified 17 miRs-miR-10b-3p, miR-10-5p, miR-17-3p, miR-21-5p, miR-151a-5p, miR-181a-5p, miR-185-5p, miR-194-5p, miR-199a-3p, miR-199b-3p, miR-212-3p, miR-363-3p, miR-548d-5p, miR-744-5p, miR-3117-3p, miR-5683 and miR-5701-significantly correlated with cardiovascular risk factors (correlation coefficient >0.2 in both directions, -value ( < 0.006, false discovery rate (FDR) <0.05). Of particular interest, miR-5701 was positively correlated with hypertension, hypercholesterolemia, and diabetes. In addition, we found that miR-629-5p and miR-98-5p were significantly correlated with acute myocardial infarction. We provide a first atlas of miR profiles in IMA samples from CAD patients. In perspective, these miRs might play an important role in improved risk assessment, mechanistic disease understanding and local therapy of CAD.

摘要

心血管疾病(CVD)是全球发病和死亡的主要原因。非编码RNA已被证明与CVD的发生和发展有关。虽然微小RNA(miRs)在血液样本中已得到充分研究,但关于心血管相关组织中组织特异性miRs及其与心血管危险因素的关系的数据却很少。对192例行冠状动脉旁路移植术(CABG)的冠心病(CAD)患者的内乳动脉(IMA)中衍生的组织特异性miRs进行了分析。该研究的目的是:1)建立一个可用于鉴定新型诊断生物标志物和潜在治疗靶点的参考图谱;2)将这些miRs与心血管危险因素联系起来。总体而言,393个个体miRs表现出足够的表达水平并通过质量控制以进行进一步分析。我们鉴定出17个miRs——miR-10b-3p、miR-10-5p、miR-17-3p、miR-21-5p、miR-151a-5p、miR-181a-5p、miR-185-5p、miR-194-5p、miR-199a-3p、miR-199b-3p、miR-212-3p、miR-363-3p、miR-548d-5p、miR-744-5p、miR-3117-3p、miR-5683和miR-5701——与心血管危险因素显著相关(双向相关系数>0.2,P值<0.006,错误发现率(FDR)<0.05)。特别值得关注的是,miR-5701与高血压、高胆固醇血症和糖尿病呈正相关。此外,我们发现miR-629-5p和miR-98-5p与急性心肌梗死显著相关。我们提供了CAD患者IMA样本中miR谱的首个图谱。从长远来看,这些miRs可能在改善CAD的风险评估、疾病机制理解和局部治疗中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/74f5c7b638b4/biomolecules-11-01683-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/7f4d668956b7/biomolecules-11-01683-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/1efd7f67e490/biomolecules-11-01683-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/559ca8d7fdcb/biomolecules-11-01683-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/74f5c7b638b4/biomolecules-11-01683-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/7f4d668956b7/biomolecules-11-01683-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/1efd7f67e490/biomolecules-11-01683-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/559ca8d7fdcb/biomolecules-11-01683-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff05/8615466/74f5c7b638b4/biomolecules-11-01683-g004.jpg

相似文献

1
Vascular Tissue Specific miRNA Profiles Reveal Novel Correlations with Risk Factors in Coronary Artery Disease.血管组织特异性微小RNA谱揭示了与冠状动脉疾病危险因素的新关联。
Biomolecules. 2021 Nov 12;11(11):1683. doi: 10.3390/biom11111683.
2
Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study.由于颈动脉狭窄导致的缺血性中风和急性冠状动脉综合征中的诊断和预后 microRNAs:一项为期四年的前瞻性研究。
Kardiol Pol. 2018;76(2):362-369. doi: 10.5603/KP.a2017.0243. Epub 2018 Jan 19.
3
Levels of miR-130b-5p in peripheral blood are associated with severity of coronary artery disease.外周血 miR-130b-5p 水平与冠状动脉疾病严重程度相关。
Mol Biol Rep. 2021 Dec;48(12):7719-7732. doi: 10.1007/s11033-021-06780-5. Epub 2021 Oct 23.
4
Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.动脉粥样硬化条件促进功能性 microRNA-92a-3p 被包装到血管内皮细胞微囊泡中。
Circ Res. 2019 Feb 15;124(4):575-587. doi: 10.1161/CIRCRESAHA.118.314010.
5
Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.探讨经血管造影证实的冠心病患者中 miR-26a-5p 和 miR-19a-3p 的表达水平。
Acta Cardiol. 2023 Oct;78(8):945-956. doi: 10.1080/00015385.2023.2227484. Epub 2023 Jun 28.
6
Involvement of Expression of miR33-5p and ABCA1 in Human Peripheral Blood Mononuclear Cells in Coronary Artery Disease.miR33-5p 和 ABCA1 在冠心病患者外周血单个核细胞中的表达及其作用
Int J Mol Sci. 2024 Aug 7;25(16):8605. doi: 10.3390/ijms25168605.
7
Associations between circulating microRNAs and coronary plaque characteristics: potential impact from physical exercise.循环微RNA与冠状动脉斑块特征之间的关联:体育锻炼的潜在影响。
Physiol Genomics. 2022 Apr 1;54(4):129-140. doi: 10.1152/physiolgenomics.00071.2021. Epub 2022 Feb 28.
8
Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events.miR-1-3p、miR-16-5p和miR-122-5p的表达作为继发性心血管事件的潜在危险因素
Biomedicines. 2021 Aug 20;9(8):1055. doi: 10.3390/biomedicines9081055.
9
MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.MiR-223-3p和miR-122-5p作为斑块不稳定的循环生物标志物。
Open Heart. 2020 Jun;7(1). doi: 10.1136/openhrt-2019-001223.
10
Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.循环 microRNA-423-3p 可改善普通人群中冠状动脉疾病的预测-来自中国心血管疾病研究的 6 年随访结果。
Circ J. 2020 Jun 25;84(7):1155-1162. doi: 10.1253/circj.CJ-19-1181. Epub 2020 May 13.

引用本文的文献

1
MicroRNA Profiling in Chronic Limb-Threatening Ischemia Their Role in Arteriogenesis.慢性肢体威胁性缺血中的微小RNA分析:它们在动脉生成中的作用
Int J Angiol. 2025 Jan 13;34(2):83-91. doi: 10.1055/a-2504-1911. eCollection 2025 Jun.
2
Cardiac shock wave therapy-induced exosome derived from OGD/R-treated H9c2 cells carrying miR-98-5p promote HUVECs angiogenesis.心脏冲击波疗法诱导的源自携带miR-98-5p的氧糖剥夺/复氧处理H9c2细胞的外泌体促进人脐静脉内皮细胞血管生成。
Sci Rep. 2025 Apr 30;15(1):15213. doi: 10.1038/s41598-025-00104-4.
3
Advances in nanotechnology for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.在超过 100 万名参与者中发现并系统地描述了冠心病的风险变异和基因。
Nat Genet. 2022 Dec;54(12):1803-1815. doi: 10.1038/s41588-022-01233-6. Epub 2022 Dec 6.
2
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
3
Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity.
用于代谢功能障碍相关脂肪性肝病诊断和管理的纳米技术进展。
Asian J Pharm Sci. 2025 Apr;20(2):101025. doi: 10.1016/j.ajps.2025.101025. Epub 2025 Feb 9.
4
The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.肌微RNA-133a-3p、-133b和-206失调在心血管疾病风险中的潜在作用
Int J Mol Sci. 2024 Nov 27;25(23):12772. doi: 10.3390/ijms252312772.
5
Inhibition of miR-194-5p avoids DUSP9 downregulation thus limiting sepsis-induced cardiomyopathy.抑制 miR-194-5p 避免了 DUSP9 的下调,从而限制了脓毒症诱导的心肌病。
Sci Rep. 2024 Sep 2;14(1):20313. doi: 10.1038/s41598-024-71166-z.
6
Identification and Validation of the miR/RAS/RUNX2 Autophagy Regulatory Network in AngII-Induced Hypertensive Nephropathy in MPC5 Cells Treated with Hydrogen Sulfide Donors.硫化氢供体处理的MPC5细胞中血管紧张素II诱导的高血压肾病中miR/RAS/RUNX2自噬调节网络的鉴定与验证
Antioxidants (Basel). 2024 Aug 7;13(8):958. doi: 10.3390/antiox13080958.
7
Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography.机器学习在10004例接受血管造影监测的冠状动脉支架置入术后再狭窄风险患者中识别出新的预测因素。
J Clin Med. 2023 Apr 18;12(8):2941. doi: 10.3390/jcm12082941.
8
miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives.miRNA 在心脑血管疾病中的失调:现状与展望。
Int J Mol Sci. 2023 Mar 8;24(6):5192. doi: 10.3390/ijms24065192.
9
Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus.2型糖尿病急性缺血性中风患者中不同循环微小RNA的鉴定。
Front Cardiovasc Med. 2022 Oct 6;9:1024790. doi: 10.3389/fcvm.2022.1024790. eCollection 2022.
10
Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease.与炎症性肠病相关的结肠 microRNAome 景观的全球改变。
Front Immunol. 2022 Sep 13;13:991346. doi: 10.3389/fimmu.2022.991346. eCollection 2022.
肝 miR-144 驱动延胡索酸酶活性,防止肥胖期间 NRF2 的激活。
Gastroenterology. 2021 Dec;161(6):1982-1997.e11. doi: 10.1053/j.gastro.2021.08.030. Epub 2021 Aug 21.
4
MicroRNAs mediated regulation of glutathione peroxidase 7 expression and its changes during adipogenesis.微小 RNA 介导的谷胱甘肽过氧化物酶 7 表达调控及其在脂肪生成过程中的变化。
Biochim Biophys Acta Gene Regul Mech. 2021 Oct;1864(10):194734. doi: 10.1016/j.bbagrm.2021.194734. Epub 2021 Jul 31.
5
miR-5701 promoted apoptosis of clear cell renal cell carcinoma cells by targeting phosphodiesterase-1B.微小RNA-5701通过靶向磷酸二酯酶-1B促进肾透明细胞癌细胞凋亡。
Anticancer Drugs. 2021 Sep 1;32(8):855-863. doi: 10.1097/CAD.0000000000001078.
6
Exosome-eluting stents for vascular healing after ischaemic injury.载有外泌体的支架促进缺血性损伤后血管愈合。
Nat Biomed Eng. 2021 Oct;5(10):1174-1188. doi: 10.1038/s41551-021-00705-0. Epub 2021 Apr 5.
7
Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism.转录因子 MAFF(MAF 碱性亮氨酸拉链转录因子 F)调节连接炎症和胆固醇代谢的动脉粥样硬化相关网络。
Circulation. 2021 May 4;143(18):1809-1823. doi: 10.1161/CIRCULATIONAHA.120.050186. Epub 2021 Feb 25.
8
Plasma MIR-212-3p as a biomarker for acute right heart failure with pulmonary artery hypertension.血浆MIR-212-3p作为肺动脉高压所致急性右心衰竭的生物标志物。
Ann Transl Med. 2020 Dec;8(23):1571. doi: 10.21037/atm-20-1653a.
9
Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix: A 5-Year Prospective Study.糖尿病心肌病的进展是由 miR122-5p 触发的,并涉及细胞外基质:一项为期 5 年的前瞻性研究。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1130-1142. doi: 10.1016/j.jcmg.2020.10.009. Epub 2020 Nov 18.
10
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.